+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Post Surgical Infection Market

  • PDF Icon

    Report

  • 300 Pages
  • January 2025
  • Region: Global
  • Expert Market Research
  • ID: 6052530
The global post-surgical infection market was valued at USD 5.9 billion in 2023, driven by the increasing number of surgical procedures worldwide. The market is projected to grow at a CAGR of 6% during the forecast period 2024-2032, reaching a market value of USD 10.2 billion by 2032.

Global Post Surgical Infection Market Analysis

Post-surgical infections, also known as surgical site infections (SSIs), occur when harmful bacteria enter the surgical wound, potentially leading to complications. These infections can be superficial, affecting the skin, or more severe, involving tissues, organs, or implanted materials. Common risk factors include prolonged surgery duration, inadequate sterilisation, compromised immunity, and pre-existing conditions like diabetes. Post-surgical infections increase patient morbidity, prolong hospital stays, and elevate healthcare costs. Preventative measures, such as antiseptic protocols, wound care products, and antibiotic prophylaxis, are critical to reducing infection rates and improving surgical outcomes.

Market Drivers

  • Increasing Number of Surgical Procedures: The rising number of surgical procedures globally, due to an ageing population and an increase in chronic diseases, is driving demand for post-surgical infection prevention products, contributing to significant market growth.
  • Advancements in Wound Care Technology: Technological advancements in wound care dressings, including antimicrobial and moisture-retentive options, are enhancing the prevention and management of post-surgical infections, thereby driving market demand for innovative wound care products.
  • Growing Awareness of Infection Control: Increased awareness about hospital-acquired infections (HAIs) and the importance of stringent infection control protocols are pushing healthcare providers to adopt advanced infection prevention measures, driving market expansion.
  • Rising Prevalence of Antibiotic Resistance: The growing threat of antibiotic-resistant infections is highlighting the need for more effective prophylactic measures, such as antiseptics and disinfectants, which are playing a crucial role in the market's growth.

Challenges

  • Rising Cases of Antibiotic Resistance: The increasing prevalence of antibiotic-resistant bacteria complicates the treatment of post-surgical infections, posing a significant challenge to healthcare providers and driving the need for new, effective treatments.
  • High Costs of Advanced Infection Control Products: While advanced infection prevention products, such as antimicrobial dressings, offer superior outcomes, their high costs can be a barrier to adoption, particularly in lower-income regions, limiting market penetration.
  • Stringent Regulatory Approvals: The strict regulatory requirements for approving new infection control products create a challenging environment for companies, slowing the introduction of innovative solutions to the market and impacting overall market growth.
  • Limited Access to Quality Healthcare in Emerging Regions: In developing countries, limited access to quality healthcare services and infection prevention products increases the risk of post-surgical infections, posing a challenge to improving patient outcomes and expanding the market.

Future Opportunities

  • Increasing Focus on Minimally Invasive Surgeries: The growing trend towards minimally invasive surgeries, which generally have lower infection risks, presents an opportunity for companies to develop and market innovative post-surgical infection prevention products for these procedures.
  • Innovation in Antimicrobial Dressings: Ongoing innovation in antimicrobial wound dressings, which offer enhanced protection against infections, provides opportunities for companies to introduce new products and capture a larger share of the growing market.
  • Collaborations Between Hospitals and Product Manufacturers: Collaborations between hospitals and infection control product manufacturers to develop and implement tailored infection prevention strategies are creating opportunities to expand market reach and enhance product effectiveness.
  • Government Funding for Infection Control Research: Increased government funding and research grants aimed at developing new solutions for infection control, particularly in the face of rising antibiotic resistance, provide opportunities for companies to innovate and grow within the market.

Global Post Surgical Infection Market Trends

The global post-surgical infection market is rapidly evolving, propelled by innovation in antimicrobial dressings and treatment approaches. As ongoing research uncovers new insights into the disease, several significant trends are emerging, shaping the future trajectory of this market.
  • Rising Demand for Antimicrobial Dressings
Antimicrobial wound dressings are gaining significant popularity due to their ability to prevent infections by releasing antimicrobial agents that target bacteria at the wound site. This trend is driving the widespread adoption of advanced wound care products in hospitals and clinics, where infection prevention is critical. The use of these dressings is particularly important in post-surgical care, as they help reduce infection rates and improve patient outcomes, contributing to market growth.
  • Growing Adoption of Single-Use Surgical Instruments
The adoption of single-use surgical instruments is steadily increasing as a means of reducing the risk of post-surgical infections. This trend is particularly prominent in hospitals and surgical centres, where infection control is a top priority. By eliminating the need for sterilisation and reducing cross-contamination risks, single-use instruments offer an effective solution for maintaining high standards of hygiene, thereby driving demand for these products in the healthcare sector.
  • Advancements in Antiseptic Solutions
Innovative antiseptic solutions with broader spectrums of activity and prolonged effects are being developed to provide enhanced infection prevention both during and after surgeries. These advancements offer more effective alternatives to traditional antiseptics, reducing the likelihood of infections in surgical wounds. As these solutions become more widely adopted, they are expected to play a pivotal role in reducing surgical site infections and contribute to the overall growth of the post-surgical infection market.
  • Shift Towards Outpatient Surgical Procedures
The increasing trend of outpatient surgical procedures is driving the demand for post-surgical infection prevention products that are easy to use outside hospital settings. As more surgeries are performed in outpatient facilities, there is a growing need for portable and user-friendly products that can be used by patients at home. This shift is expected to encourage innovation in infection prevention products, leading to market growth as these solutions become more accessible to patients.
  • Increasing Focus on Reducing Healthcare-Associated Infections
Healthcare providers are placing an increasing emphasis on reducing healthcare-associated infections (HAIs) by implementing stricter infection control protocols and adopting advanced infection prevention products. This focus on preventing infections within healthcare settings is shaping the future of the post-surgical infection market, as hospitals and clinics invest in the latest solutions to improve patient safety and reduce the incidence of post-surgical infections.
  • Increased Research on Prophylactic Antibiotic Alternatives
The rise of antibiotic resistance is prompting significant research into alternatives to prophylactic antibiotics, traditionally used to prevent post-surgical infections. This research is leading to the development of new antiseptics, disinfectants, and advanced wound care products designed to provide effective infection prevention without relying on antibiotics. As these alternatives emerge, they are expected to drive innovation and growth in the post-surgical infection market.

Global Post Surgical Infection Market Segmentation

Market Breakup by Product Type

  • Wound Care Dressing
  • Clippers
  • Antibiotic Prophylaxis Products
  • Antiseptics and Disinfectants
  • Others
The market is segmented by product type into wound care dressings, clippers, antibiotic prophylaxis products, and antiseptics and disinfectants. Wound care dressings, particularly antimicrobial options, are widely used to prevent post-surgical infections. Antibiotic prophylaxis products are also critical in reducing the risk of infection, especially in high-risk surgeries. Antiseptics and disinfectants are essential for maintaining a sterile surgical environment, while clippers are used to minimise infection risk during pre-operative preparations. Other products include innovations that address specific surgical infection concerns.

Market Breakup by Type

  • Superficial Incisional Infection
  • Space Infection
  • Deep Incisional Infection
Post-surgical infections are classified into superficial incisional, deep incisional, and space infections. Superficial infections affect only the skin and are typically less severe, while deep incisional infections involve deeper tissues. Space infections, which affect organs or cavities, are the most serious and often require more intensive treatment. Each infection type requires specific management strategies, contributing to the demand for varied infection control products.

Market Breakup by End User

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers
  • Others
Hospitals are the largest end-user segment due to the high volume of surgeries performed and the need for stringent infection control protocols. Speciality clinics and ambulatory surgical centres are also key end-users, particularly as outpatient surgical procedures increase. These facilities require effective infection prevention measures to minimise post-surgical complications. Other end-users include long-term care facilities and home healthcare settings, where post-surgical patients may require ongoing infection prevention support.

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
North America leads the global post-surgical infection market due to its advanced healthcare infrastructure and strict infection control regulations. Europe follows, driven by increasing surgical volumes and government initiatives to reduce healthcare-associated infections. The Asia Pacific region is expected to see significant growth, supported by expanding healthcare access and rising awareness of infection prevention. Latin America and the Middle East and Africa are emerging markets, where improving healthcare systems and increasing surgical procedures are driving market expansion.

Global Post Surgical Infection Market Competitive Landscape

The competitive landscape of the global post-surgical infection market includes major players such as BD, 3M, Smith+Nephew, Medtronic, Convatec, Johnson & Johnson, Inc., B. Braun SE, and Molnlycke Healthcare AB. These companies are developing advanced infection-prevention products, including wound care dressings, antiseptics, and disinfectants. They focus on innovation, strategic partnerships, and mergers to strengthen their market positions. Ongoing research and development, aimed at addressing rising antibiotic resistance and improving patient outcomes, is expected to drive further competition in the market.Key Questions Answered in the Report

  • What are the key drivers contributing to the expansion of the post-surgical infection market?
  • How are advancements in wound care technology shaping the market for post-surgical infection prevention products?
  • What challenges are healthcare providers facing in addressing post-surgical infections, particularly in low-income regions?
  • How is the growing threat of antibiotic resistance influencing the development of alternative infection control products?
  • What role do government initiatives play in promoting infection prevention measures in hospitals and surgical centres?
  • How are minimally invasive surgeries impacting the demand for post-surgical infection prevention products?
  • What opportunities exist for market growth in emerging regions, such as Asia Pacific and Latin America?
  • How are collaborations between hospitals and product manufacturers driving innovation in infection control strategies?
  • What trends are shaping the demand for antimicrobial wound dressings in the post-surgical infection market?
  • How is the shift towards outpatient surgical procedures influencing the development of user-friendly infection prevention products?
  • What competitive strategies are companies employing to maintain leadership in the global post-surgical infection market?

Key Benefits for Stakeholders

  • The industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the global post-surgical infection market from 2017-2032.
  • The research report provides the latest information on the market drivers, challenges, and opportunities in global post-surgical infection.
  • The study maps the leading, as well as the fastest-growing, regional markets. It further enables stakeholders to identify the key country-level markets within each region.
  • Porter's five forces analysis assists stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders analyze the level of competition within the global post-surgical infection industry and its attractiveness.
  • The competitive landscape allows stakeholders to understand their competitive environment and provides insight into the current positions of key players in the market.

This product will be delivered within 5-7 business days.

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Post Surgical Infection Market Overview
3.1 Global Post Surgical Infection Market Historical Value (2017-2023)
3.2 Global Post Surgical Infection Market Forecast Value (2024-2032)
4 Vendor Positioning Analysis
4.1 Key Vendors
4.2 Prospective Leaders
4.3 Niche Leaders
4.4 Disruptors
5 Global Post Surgical Infection Market Landscape
5.1 Global Post Surgical Infection Market: Developers Landscape
5.1.1 Analysis by Year of Establishment
5.1.2 Analysis by Company Size
5.1.3 Analysis by Region
5.2 Global Post Surgical Infection Market: Product Landscape
5.2.1 Analysis by Product Type
5.2.2 Analysis by Type
6 Global Post Surgical Infection Market Dynamics
6.1 Market Drivers and Constraints
6.2 SWOT Analysis
6.2.1 Strengths
6.2.2 Weaknesses
6.2.3 Opportunities
6.2.4 Threats
6.3 PESTEL Analysis
6.3.1 Political
6.3.2 Economic
6.3.3 Social
6.3.4 Technological
6.3.5 Legal
6.3.6 Environment
6.4 Porter’s Five Forces Model
6.4.1 Bargaining Power of Suppliers
6.4.2 Bargaining Power of Buyers
6.4.3 Threat of New Entrants
6.4.4 Threat of Substitutes
6.4.5 Degree of Rivalry
6.5 Key Demand Indicators
6.6 Key Price Indicators
6.7 Industry Events, Initiatives, and Trends
6.8 Value Chain Analysis
7 Global Post Surgical Infection Market Segmentation (2018-2034)
7.1 Global Post Surgical Infection Market (2018-2034) by Product Type
7.1.1 Market Overview
7.1.2 Wound Care Dressing
7.1.3 Clippers
7.1.4 Antibiotic Prophylaxis Products
7.1.5 Antiseptics & Disinfectants
7.1.6 Others
7.2 Global Post Surgical Infection Market (2018-2034) by Type
7.2.1 Market Overview
7.2.2 Superficial Incisional Infection
7.2.3 Space Infection
7.2.4 Deep Incisional Infection
7.3 Global Post Surgical Infection Market (2018-2034) by End User
7.3.1 Market Overview
7.3.2 Hospitals
7.3.3 Specialty Clinics
7.3.4 Ambulatory Surgical Centers
7.3.5 Others
7.4 Global Post Surgical Infection Market (2018-2034) by Region
7.4.1 Market Overview
7.4.2 North America
7.4.3 Europe
7.4.4 Asia Pacific
7.4.5 Latin America
7.4.6 Middle East and Africa
8 North America Post Surgical Infection Market (2018-2034)
8.1 North America Post Surgical Infection Market (2018-2034) by Product Type
8.1.1 Market Overview
8.1.2 Wound Care Dressing
8.1.3 Clippers
8.1.4 Antibiotic Prophylaxis Products
8.1.5 Antiseptics & Disinfectants
8.1.6 Others
8.2 North America Post Surgical Infection Market (2018-2034) by Type
8.2.1 Market Overview
8.2.2 Superficial Incisional Infection
8.2.3 Space Infection
8.2.4 Deep Incisional Infection
8.3 North America Post Surgical Infection Market (2018-2034) by End User
8.3.1 Market Overview
8.3.2 Hospitals
8.3.3 Specialty Clinics
8.3.4 Ambulatory Surgical Centers
8.3.5 Others
8.4 North America Post Surgical Infection Market (2018-2034) by Country
8.4.1 United States of America
8.4.2 Canada
9 Europe Post Surgical Infection Market (2018-2034)
9.1 Europe Post Surgical Infection Market (2018-2034) by Product Type
9.1.1 Market Overview
9.1.2 Wound Care Dressing
9.1.3 Clippers
9.1.4 Antibiotic Prophylaxis Products
9.1.5 Antiseptics & Disinfectants
9.1.6 Others
9.2 Europe Post Surgical Infection Market (2018-2034) by Type
9.2.1 Market Overview
9.2.2 Superficial Incisional Infection
9.2.3 Space Infection
9.2.4 Deep Incisional Infection
9.3 Europe Post Surgical Infection Market (2018-2034) by End User
9.3.1 Market Overview
9.3.2 Hospitals
9.3.3 Specialty Clinics
9.3.4 Ambulatory Surgical Centers
9.3.5 Others
9.4 Europe Post Surgical Infection Market (2018-2034) by Country
9.4.1 United Kingdom
9.4.2 Germany
9.4.3 France
9.4.4 Italy
9.4.5 Others
10 Asia Pacific Post Surgical Infection Market (2018-2034)
10.1 Asia Pacific Post Surgical Infection Market (2018-2034) by Product Type
10.1.1 Market Overview
10.1.2 Wound Care Dressing
10.1.3 Clippers
10.1.4 Antibiotic Prophylaxis Products
10.1.5 Antiseptics & Disinfectants
10.1.6 Others
10.2 Asia Pacific Post Surgical Infection Market (2018-2034) by Type
10.2.1 Market Overview
10.2.2 Superficial Incisional Infection
10.2.3 Space Infection
10.2.4 Deep Incisional Infection
10.3 Asia Pacific Post Surgical Infection Market (2018-2034) by End User
10.3.1 Market Overview
10.3.2 Hospitals
10.3.3 Specialty Clinics
10.3.4 Ambulatory Surgical Centers
10.3.5 Others
10.4 Asia Pacific Post Surgical Infection Market (2018-2034) by Country
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 ASEAN
10.4.5 Australia
10.4.6 Others
11 Latin America Post Surgical Infection Market (2018-2034)
11.1 Latin America Post Surgical Infection Market (2018-2034) by Product Type
11.1.1 Market Overview
11.1.2 Wound Care Dressing
11.1.3 Clippers
11.1.4 Antibiotic Prophylaxis Products
11.1.5 Antiseptics & Disinfectants
11.1.6 Others
11.2 Latin America Post Surgical Infection Market (2018-2034) by Type
11.2.1 Market Overview
11.2.2 Superficial Incisional Infection
11.2.3 Space Infection
11.2.4 Deep Incisional Infection
11.3 Latin America Post Surgical Infection Market (2018-2034) by End User
11.3.1 Market Overview
11.3.2 Hospitals
11.3.3 Specialty Clinics
11.3.4 Ambulatory Surgical Centers
11.3.5 Others
11.4 Latin America Post Surgical Infection Market (2018-2034) by Country
11.4.1 Brazil
11.4.2 Argentina
11.4.3 Mexico
11.4.4 Others
12 Middle East and Africa Post Surgical Infection Market (2018-2034)
12.1 Middle East & Africa Post Surgical Infection Market (2018-2034) by Product Type
12.1.1 Market Overview
12.1.2 Wound Care Dressing
12.1.3 Clippers
12.1.4 Antibiotic Prophylaxis Products
12.1.5 Antiseptics & Disinfectants
12.1.6 Others
12.2 Middle East & Africa Post Surgical Infection Market (2018-2034) by Type
12.2.1 Market Overview
12.2.2 Superficial Incisional Infection
12.2.3 Space Infection
12.2.4 Deep Incisional Infection
12.3 Middle East and Africa Post Surgical Infection Market (2018-2034) by End User
12.3.1 Market Overview
12.3.2 Hospitals
12.3.3 Specialty Clinics
12.3.4 Ambulatory Surgical Centers
12.3.5 Others
12.4 Middle East and Africa Post Surgical Infection Market (2018-2034) by Country
12.4.1 Saudi Arabia
12.4.2 United Arab Emirates
12.4.3 Nigeria
12.4.4 South Africa
12.4.5 Others
13 Regulatory Framework
13.1 Regulatory Overview
13.2 US FDA
13.3 EU EMA
13.4 INDIA CDSCO
13.5 JAPAN PMDA
13.6 Others
14 Patent Analysis
14.1 Analysis by Type of Patent
14.2 Analysis by Publication Year
14.3 Analysis by Issuing Authority
14.4 Analysis by Patent Age
14.5 Analysis by CPC Analysis
14.6 Analysis by Patent Valuation
15 Funding and Investment Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Drug Type of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Strategic Initiatives
16.1 Analysis by Partnership Instances
16.2 Analysis by Type of Partnership and Collaborations
16.3 Analysis by Joint Ventures
16.4 Analysis by Leading Players
16.5 Analysis by Geography
16.6 Analysis by Merger & Acquisitions
17 Supplier Landscape
17.1 Market Share Analysis, By Region (Top 5 Companies)
17.1.1 Market Share Analysis: Global
17.1.2 Market Share Analysis: North America
17.1.3 Market Share Analysis: Europe
17.1.4 Market Share Analysis: Asia Pacific
17.1.5 Market Share Analysis: Others
17.2 BD
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Company News and Development
17.2.5 Certifications
17.3 3M
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Company News and Development
17.3.5 Certifications
17.4 Smith+Nephew
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Company News and Development
17.4.5 Certifications
17.5 Medtronic
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Company News and Development
17.5.5 Certifications
17.6 Convatec
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Company News and Development
17.6.5 Certifications
17.7 Johnson & Johnson, Inc.
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Company News and Development
17.7.5 Certifications
17.8 B. Braun SE
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Company News and Development
17.8.5 Certifications
17.9 Molnlycke Healthcare AB
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Company News and Development
17.9.5 Certifications
18 Global Post Surgical Infection Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
*Additional insights provided are customisable as per client requirements.
*The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The team strives to make this section as comprehensive as possible.
**The supplier list is not exhaustive. Moreover, we can provide analysis of companies as per custom requests.

Companies Mentioned

  • BD
  • 3M
  • Smith_Nephew
  • Medtronic plc
  • Convatec

Methodology

Loading
LOADING...

Table Information